Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics. The agreement includes the global rights to three established brands (Zinnat®, Zinacef® and Fortum®)) in more than 100 markets.
Homepage
Explore Novartis
Over ons
Ons werk
Loopbaan
Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics
Novartis 2020 Financial Results
Sandoz officially certified as Global Top Employer 2021
Sandoz, a Novartis division, is pleased to announce that it has been officially awarded “Global Top Employer 2021” certification for the third year in a row. This year, Sandoz was one of only 16 Top Employers recognized for their outstanding HR policies and practices worldwide by the Top Employers Institute.
Sandoz schenkt hydroxychloroquine tabletten aan België
De Novartis-groep heeft zich ertoe verbonden om wereldwijd 130 miljoen dosissen van het antimalariamiddel hydroxychloroquine te schenken ter ondersteuning van de strijd tegen de COVID-19 pandemie. België is één van de landen die deze schenking ontvangt.